ARCHIVES

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Center Directors Offer Each Other Advice On how To Prepare for, Handle Reviewers

December 16, 1977

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Trimodality Therapy Improves Survival In Early Disease

January 27, 2006

Moloney Out As Viral Oncology Chief, Names “Acting Assistant Director” Of NCI By Upton

January 6, 1978